QuadraMed® Corporation (Amex:QD - News) today announced that QuadraMed Affinity® has again been honored with a "Best in KLAS" award in the General Market Solutions "Acute Care Registration, Scheduling & Patient Accounting" category. This is the company's third consecutive award and fourth overall in this category. QuadraMed Affinity has received eight Best in KLAS awards since 1999.
The latest awards and product rating information are available in the 2006 "Top 20 Best in KLAS Awards" released this month. KLAS® product ratings are determined from detailed responses by healthcare providers as compiled over a 13-month period by KLAS Enterprises, LLC.
Acute Care Registration, Scheduling & Patient Accounting includes "products that provide some or all of inpatient 'core' systems in support of Patient Management (ADT), Patient Accounting (billing, A/R, contract management), Basic Scheduling, Medical Records and General Financials." Medium to large hospitals (over 200 beds) are targeted in this market segment.
In product ratings, QuadraMed MPI (Master Patient Index) earned the top rating for General Market Solutions in the EMPI category. This is the second consecutive first place finish for QuadraMed's patient identity management solution. Also, in the Community Hospital Solutions (facilities under 200 beds) "Community Clinical Ancillary Solutions" category, QuadraMed Pharmacy earned the number one rating from users of current products for the fourth consecutive KLAS Year-End report.
QuadraMed delivers comprehensive healthcare IT solutions that form the foundational components of the Care-Based Revenue Cycle(TM) process. This QuadraMed strategic process enables healthcare organizations to achieve improved financial performance by leveraging quality care into positive financial outcomes, while providing interoperability for the connected healthcare community and quality measurement.
More about KLAS Enterprises is available at www.healthcomputing.com. Further information about QuadraMed, its products and related services is available by visiting www.quadramed.com, or by calling 800-393-0278.
About KLAS Enterprises
Founded in 1996, KLAS is the only research firm specializing in monitoring and reporting the performance of healthcare information technology (HIT) vendors and products. KLAS strives to improve HIT delivery by independently measuring vendor performance for the benefit of consultants, investors, vendors, and healthcare provider partners. KLAS, in concert with thousands of healthcare executives and professionals, has created a dynamic database of HIT evaluations and opinions of healthcare executives, managers, and clinicians from over 4,500 healthcare facilities and 2500 clinics on 500+ HIT products from 175+ vendors. The Top 20 Report reflects the summary of HIT product performance data collected over a 13-month period. For further information, contact KLAS Enterprises, LLC at 800-920-4109 or on the Web at www.healthcomputing.com.
About QuadraMed Corporation
QuadraMed Corporation advances the success of healthcare organizations through IT solutions that leverage quality care into positive financial outcomes. As evolving reimbursement scenarios challenge healthcare organizations to leverage quality of care into payment, clients committing to QuadraMed's care-based solutions can realize market leading financial performance. Using QuadraMed's end-to-end solutions to optimize the patient experience and leverage quality of care into payment, our clients can receive the proper reimbursement, in the shortest time, at the lowest administrative cost. Behind our products and services is a staff of almost 600 professionals whose experience and dedication to service have earned QuadraMed the trust and loyalty of customers at approximately 2,000 healthcare provider facilities. To find out more about QuadraMed, visit www.quadramed.com.
Cautionary Statement on Risks Associated with QuadraMed's Forward-Looking Statements
This press release contains forward-looking statements, as defined in Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934, by QuadraMed that are subject to risks and uncertainties. The words "believe," "expect," "anticipate," "intend," "plan," "estimate," "may," "should," "could," and similar expressions are intended to identify such statements. Forward-looking statements are not guarantees of future performance and are to be interpreted only as of the date on which they are made. QuadraMed undertakes no obligation to update or revise any forward-looking statement except as required by law. QuadraMed advises investors that it discusses risk factors and uncertainties that could cause QuadraMed's actual results to differ from forward-looking statements in its periodic reports filed with the Securities and Exchange Commission ("SEC"). QuadraMed's SEC filings can be accessed through the Investor Relations section of our website, www.quadramed.com, or through the SEC's EDGAR Database at www.sec.gov (QuadraMed has EDGAR CIK No. 0001018833).
Information from the "Top 20 Year-End Best in KLAS Awards" is ©2006 KLAS Enterprises, LLC. All Rights Reserved. QuadraMed and Affinity are registered trademarks of QuadraMed Corporation. Care-Based Revenue Cycle is a trademark of QuadraMed Corporation. All other trademarks are the property of their respective holders.
Source: QuadraMed Corporation
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment